Another cholesterol drug seeks OTC status
Now Pravachol is up to the plate. It too will be unlikely to be approved for OTC status. The pharmaceuticals are desperate to salvage profits in light of their expiring statin patents.
Another cholesterol drug seeks OTC status
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Hidden fees in employer health plans are about to come out
Bringing a newborn home? What hospitals don’t tell new parents
Is your clinical AI tool safe? 4 questions to ask first
Physician pay won’t budge for one doctor. Negotiate as a group.
Shy doctors can lead: imposter syndrome and the path to physician leadership
Clinical trials answer drug questions. Health questions need other tools.
Fired for seeing her own patients: moral injury and life after medicine
